Michael Feld - 26 Nov 2025 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP, CRO & Pres. Life Sciences
Signature
Donna Kalazdy, by power of attorney from Michael Feld
Issuer symbol
BDX
Transactions as of
26 Nov 2025
Transactions value $
$0
Form type
4
Filing time
01 Dec 2025, 12:06:25 UTC
Previous filing
28 Oct 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feld Michael EVP, CRO & Pres. Life Sciences C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES Donna Kalazdy, by power of attorney from Michael Feld 01 Dec 2025 0002034349

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +8.83K +107.08% $0.00 17.1K 26 Nov 2025 Direct F1
transaction BDX Common Stock Tax liability $0 -419 -2.45% $0.00 16.7K 26 Nov 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.